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Figure 2. Nissl stained section through a
normal macaque monkey’s LGN.
P, parvocellular layers; M, magnocellular
layers; I, interlaminar layers. Adapted with
permission from [17].
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R704stimuli in the field defect. But when
the lateral geniculate nucleus was
reversibly inactivated by the GABA
agonist THIP — the effective region
of which was visualised by concurrent
structural magnetic imaging and by
also injecting the magnetic resonance
contrast-agent gadolinium — both the
extrastriate activity and the behavioural
discrimination were abolished.
As the GABA agonist does not affect
the retinal axons passing beneath theLGN en route to the superior colliculus,
the role of the latter and other mid-brain
centres in blindsight has to be
re-evaluated. Further steps are likely
to includewhether thepathway fromeye
tosuperiorcolliculus is indeed important
but that the output from superior
colliculus is routed via the interlaminar
layers of the LGN. It will also be
important to record from the amygdala,
often implicated in affective blindsight
[15,16] such as responses to emotional
visual stimuli, in order to determine
whether the amygdala has a privileged
visual input that is independent of the
LGN and might involve the collicular
projections to the pulvinar nucleus and/
or themedial dorsal thalamus. Lastly, as
icing on the cake, it should be possible
to demonstrate behaviourally that such
monkeys are displaying blindsightwhen
they respond. It seems that the
resolution of a longstanding problem
is at last in sight.
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RNA Polymerase II ElongationShort interfering RNAs trigger histone silencing marks and stalling of RNA
polymerase II at their genomic target sites through a mechanism termed
transcriptional gene silencing (TGS). TheArgonaute protein NRDE-3, alongwith
NRDE-2, are needed for TGS in C. elegans. TGS also inhibits elongation and
controls alternative splicing in mammalian cells.Mariano Allo´
and Alberto R. Kornblihtt*
Three types of small, double-stranded
RNAs play fundamental regulatory
roles in eukaryotic cells. Although
they share many functions, theseRNAs differ in length, internal
complementarity, protein partners
and mechanisms of action. Whereas
short interfering RNAs (siRNAs)
and microRNAs (miRNAs) are 21–25
nucleotides long, PIWI-interacting
RNAs (piRNAs) are 24–31 nucleotideslong. The two strands of siRNAs and
piRNAs are fully complementary, while
a distinctive feature of miRNAs is the
presence of internal mismatches. All
three types are able to trigger
degradation or translational arrest of
mRNAs carrying target sequences in
a cytoplasmic process known as
post-transcriptional gene silencing
(PTGS). PTGS elicited by transfection
of siRNAs targeting specific mRNAs
has become one of the most powerful
tools to knockdown gene expression
in mammalian cells and study gene
function in a rapid, affordable and
robust way. A second mechanism
triggered by small RNAs, termed
transcriptional gene silencing (TGS), is
Guide
strand 
A TGS B TGS-AS
siRNA
Passenger
strand 
NRDE-3
NRDE-3
NRDE-2
Pol II
Roadblock to Pol II
CH3CH3CH3
Pol II
H3K9 trimethylation
NRDE-2
NRDE-2
NRDE-3
NRDE-3
siRNA target site
Current Biology
DownstreamUpstream
pre-mRNA [nrde-2 (-)]
pre-mRNA [nrde-2 (+)]
Pol II [nrde-2 (-)]
Pol II [nrde-2 (-)]
H3K9 dimethylation
Intronic
siRNA 
Guide
strand 
Passenger
strand 
Higher alternative exon
inclusion 
AGO 1
HP1α
HP1α
H3K27 trimethylation
Roadblock to Pol II
CH3CH3CH3
Pol II
CH3CH3CH3
Pol II
AGO 1
AGO 1
Pol II
Figure 1. Transcriptional gene silencing (TGS) and TGS-regulated alternative splicing
(TGS-AS).
(A) A model for TGS in C. elegans. The argonaute protein NRDE-3 transports siRNAs from
the cytoplasm to the nucleus. Another argonaute protein, NEDE-2, is necessary for the
base pairing between the siRNA guide strand and nascent RNA. This interaction promotes
trimethylation of H3K9 (nucleosomes in brown) and subsequent stalling of RNA polymerase
II (Pol II). The graph at the bottom illustrates the dramatic decrease in pre-mRNA abundance
downstream of the siRNA target site upon siRNA action. This decrease is observed in wild-
type (solid blue line) but not in nrde-2(-) worms (solid red line). Chromatin immunoprecipita-
tion analysis reveals a peak for Pol II at the siRNA target region in wild-type (broken blue
line) but not in nrde-2(-) worms (broken red line). Based on Guang et al. [7]. (B) A model
for TGS-AS in human cells. Transfection with siRNAs targeting the intron mapping down-
stream of the alternative exon (dark yellow) promotes dimethylation and trimethylation of
H3K9 and H3K27, respectively (nucleosomes in brown). Silencing is triggered by a silencing
complex involving an siRNA guide strand and AGO1. HP1a is recruited and the resulting
condensed chromatin structure generates roadblocks to Pol II elongation, causing higher
inclusion of the alternative exon according to the kinetic coupling model. Based on Allo´
et al. [4].
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R705much less known among the non-
specialists but certainly not less
important. Unlike PTGS, TGS is
a nuclear mechanism that does not act
on the mRNA molecule itself but at the
gene level, by affecting the template
chromatin structure in such a way that
transcription is inhibited around the
small RNA target site. TGS was
discovered in plants, in which small
RNAs produced from transgenes
promote methylation of homologous
endogenous DNA sequences and
histone H3 lysine 9 (H3K9), silencing
the expression of such sequences.
The generation and maintenance of
transcriptionally silent centromeric
heterochromatin in unicellular
eukaryotes like the yeast
Schizosaccharomyces pombe and the
ciliate Tetrahymena is also the result
of TGS. Several reports confirm the
existence of TGS mechanisms in
Drosophila and Caenorhabditis
elegans (for a comprehensive review
see [1]). In all previous cases, TGS
requires Dicer-like enzymes to
generate the small RNAs and one or
more types of Argonaute proteins:
AGO4 in plants, the single AGOs of
S. pombe and Tetrahymena, and
AGO2 and PIWI in Drosophila and C.
elegans. Another common feature is
the need for base pairing between the
small RNA strand (guide strand)
interacting with the AGO-containing
silencing complex and the nascent
target RNA of the gene where the
chromatin structure change is
introduced.
TGS has also been reported to
occur in mammalian cells, although
evidence for an endogenous pathway
is lacking. Exogenously applied
siRNAs targeting promoter regions
cause transcriptional inhibition in
human cells via recruitment of
chromatin modifying enzymes that
create typical heterochromatin marks
at the target sites: H3K9
dimethylation (H3K9me2), H3K27
trimethylation (H3K27me3), DNA
methylation and histone deacetylation
[2,3]. These effects require both
AGO1 and AGO2 and the siRNA
guide strand is supposed to base
pair with RNA encoded by the
promoter resulting from genome-wide
pervasive transcription. Inspired by
mammalian TGS, we recently
showed that if, instead of targeting
promoters, siRNAs are directed to
sequences in the body of a gene,
mapping at the intron downstream ofan alternative exon, the siRNA leading
strand base-pairs with the nascent
pre-mRNA and subsequently
generates a closed chromatin
structure that, by creating
a roadblock to RNA polymerase II
(Pol II) elongation, affects alternative
splicing [4]. The effect needs both
AGO1 and AGO2 and is abolished or
reduced by factors that favor an open
chromatin structure or increase
transcriptional elongation. The
mechanism, named TGS-regulated
alternative splicing (TGS-AS), involves
the formation of facultative
heterochromatin histone marks
(H3K9me2 and H3K27me3) at thetarget site and downstream, plus the
recruitment of the heterochromatin
protein HP1. These chromatin
changes affect the kinetic coupling
mechanism between alternative
splicing and transcription according
to which the rate of transcription
elongation determines the outcome
of two competing splicing reactions
that occur co-transcriptionally.
Rapid, highly processive
transcription favors exon skipping,
whereas slower, less processive
transcription favors the inclusion
process [5,6].
A recent report published in Nature
by the Kennedy group [7] elucidates
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R706the precise roles of two C. elegans
Argonaute factors involved in TGS
and, more importantly, confirms the
importance of TGS in the control
of transcriptional elongation. The
C. elegans Argonaute protein
NRDE-3 was known to transport
siRNAs from the cytoplasm to the
nucleus and therefore to be necessary
for TGS. Guang et al. [7] identified
a new protein, NRDE-2, which is also
necessary for nuclear RNA
interference (RNAi) (TGS). In fact,
nrde-2 mutant worms fail to both
silence specific targets of exogenous
siRNAs and produce the dramatic
multivulva phenotype induced by RNAi
targeting of the endogenous nuclear
lin-15b RNA. NRDE-2 is a 130 kDa
nuclear protein containing
a conserved domain of unknown
function (DUF) and two domains
usually found in RNA processing
factors: a serine/arginine-rich domain
typical of SR proteins and a half-a-
tetratricopeptide (HAT)-like domain.
Most interesting, NRDE-2 has single
orthologues in plants, S. pombe,
Drosophila and mammals. The authors
demonstrate that NRDE-2 functions
downstream of NRDE-3 as NRDE-2
mutations do not affect siRNA
transport to the nucleus, but this
transport per se is not sufficient to
trigger TGS. Within the nucleus,
siRNA–NRDE-3–NRDE-2 complexes
are recruited to nascent pre-mRNAs
containing target sequences through
base pairing with the siRNA guide
strand. Several experiments suggest
that NRDE-2 dependent TGS inhibits
Pol II during elongation. Efficient
silencing in C. elegans is dependent
on the Rpb-7 subunit of Pol II,
previously found to be necessary for
siRNA-mediated heterochromatin
formation in S. pombe [8]. As in
TGS-AS, siRNAs complexed with
NRDE-3 and NRDE-2 interact with
unspliced mRNAs, thought to be
processed co-transcriptionally.
Furthermore, in an NRDE-2-dependent
manner, siRNAs elicit H3K9
trimethylation at the target genomic
sites and silencing of transcription,
but only downstream of the siRNA
target site, which was detected both
by steady-state pre-mRNA
quantification and run-on analysis.
Finally, and most conclusively,
chromatin immunoprecipitation
experiments using anti-Pol II
antibodies demonstrate that Pol II
peaks at the siRNA target sites innrde-2(+) but not in nrde-2(-) cells.
The Pol II peak detected in C. elegans
parallels the transcriptional roadblock
postulated to explain the reduction
in elongation observed in TGS-AS in
human cells [4]. Figure 1 compares
the mechanisms for TGS in C. elegans
and TGS-AS in human cells.
These findings highlight the role of
RNAi-mediated chromatin modification
in the expression of genes not
embedded in constitutive
heterochromatin regions like
pericentromeric chromatin or highly
repetitive sequences. In euchromatic
genes, siRNAs can create local,
intragenic and restricted
heterochromatin marks that would
affect Pol II elongation. When
transcription is inhibited at the initiation
level, only the quantity of the resulting
mRNA can be affected. Instead,
inhibition of elongation not only
affects the quantity but also the quality
of the produced mRNA by influencing
pre-mRNA processing events such as
splicing.
Many questions remain
unanswered. What is the function of
the NERD-2 orthologue of
mammalian cells? Is it necessary for
mammalian TGS? Both the
NERD-2-dependent TGS in C. elegans
and mammalian TGS-AS were
demonstrated for exogenous siRNAs.
Are there endogenous small RNAs
playing similar roles? Potential
candidates are Piwi RNAs [9] and
endogenous siRNAs (esiRNAs) [10],
which have been shown to regulate
gene expression in mammalian cells
through histone modifications and
DNA methylation; miRNAs, recently
shown to trigger TGS in the moss
Physcomitrella patens [11] and
mammalian cells [12], and
double-stranded RNAs resulting
from bidirectional and overlapping
transcription, and which trigger
epigenetic silencing, are also good
candidates [13]. Finally, the possibility
that intragenic TGS may control
alternative splicing in mammalian
cells depending on the siRNA target
site raises the converse question of
whether NRDE-2-dependent TGS
controls essential pre-mRNA
processing mechanisms in C. elegans
such as trans-splicing.
The results reported by Guang et al.
[7] contribute to our evolving view of
gene expression, from PTGS to TGS,
from chromatin/transcription at
promoters to the interior of genes,from initiation to elongation and
from putative uniform distributions
of Pol II molecules along a gene to
a landscape of intragenic Pol II peaks
representing barriers to elongation.
Most importantly, a detailed knowledge
of the mechanisms controlling
intragenic chromatin modifications
will have a significant impact on the
emerging field concerned with the
relationship between chromatin and
splicing [14,15].References
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Thermometer Works by Measuring
Membrane ThicknessCells detect external chemical stimuli by directly binding a signaling molecule,
but the strategies used by cells to detect and respond to non-chemical cues
have been mysterious. Recent work suggests that a bacterial protein detects
changes in environmental temperature by physically measuring membrane
thickness.Kumaran S. Ramamurthi
The ability to sense environmental
conditions and mount an adaptive
transcriptional response is conserved in
all domains of life. Moreover, reversible
proteinphosphorylation is awidespread
mechanistic strategy for the intracellular
transduction of extracellular signals. In
bacteria, a paradigmatic signal
transduction mechanism (appropriately
termed a ‘two-component system’)
utilizes just two proteins [1]. The first is
a transmembrane protein called
a ‘sensor kinase’ that detects an
environmental signal and transmits
the information to the interior of the cell.
Sensor kinases have two functional
domains: a signal recognition domain
(often extracellular) that may physically
bind to a ligand, and an intracellular
autokinase domain that contains
a characteristic histidine residue [2].
Detection of an environmental signal
activates the autokinase domain and
results in phosphorylation of this
histidine. The second component of
the system is canonically a soluble
transcription factor called a ‘response
regulator’, which is activated when it
accepts the phosphoryl group from its
cognate sensor kinase. The response
regulator then typically activates the
transcription of appropriate genes that
respond to the extracellular stress.
In this model, chemical factors, such as
salts, nutrients, and signaling peptides,
may be detected by direct binding
of these ligands to the sensor
kinase, leading to its activationby autophosphorylation (Figure 1A).
How, though, canasensorkinasedetect
a more abstract, non-chemical
environmental cue such as
temperature?
In this issue, Cybulski et al. [3] report
their studies on the Bacillus subtilis
sensor kinase DesK, which is activated
in response to reduced temperature [4].
Specifically, the authors wondered
if there is a physical feature of the
cell which changes in response to
fluctuations in temperature that DesK
may physically detect and exploit as an
indirect measure for temperature. The
plasma membrane of the bacterium
was a key candidate for harboring this
physical feature for two reasons. First,
DesK is a polytopic membrane protein
[4]. Second, previous studies had
demonstrated that increasing the
fluidity of the plasma membrane
by increasing the incorporation of
branched-chain fatty acids decreased
the activation of DesK, suggesting that
DesK directly responds to a physical
property of the plasma membrane [5].
NowCybulski et al. [3] propose amodel
in which DesK detects an increase in
the thickness of the plasma membrane
upon a drop in temperature, resulting
in DesK activation.
The authors began by performing
a systematic deletion analysis of the
unwieldy five-pass integral membrane
protein and discovered that deletion
of just the first transmembrane region
(TM1) abolished the ability of DesK
to respond to lower temperature
and resulted in a constitutivelyactive protein, suggesting that TM1
harbored a temperature-sensing
motif. Meanwhile, previous structural
studies had indicated that the last
transmembrane helix of DesK (TM5)
is attached to the autokinase domain
through a two helical coiled-coil
motif that appeared to be critical
for regulation of DesK activity [6].
The authors envisioned a model in
which TM1 would detect a drop in
temperature and transmit that
information to TM5, which would then
activate DesK. They therefore created
a chimeric transmembrane region,
consisting of amino-terminal residues
of TM1 and carboxy-terminal residues
of TM5, and fused it to the autokinase
domain. Remarkably, this simplified
DesK, harboring a single engineered
transmembrane segment (the minimal
thermo-sensor), worked almost as well
as wild-type DesK harboring five
membrane-spanning helices.
Curiously, the amino terminus of the
minimal thermo-sensor contained
a cluster of hydrophilic amino acids
near the lipid–water interface. At high
temperatures, when lipids are
disordered and the bilayer is thinner,
the authors reasoned that these
residues could ‘‘float’’ on the
membrane surface, like a buoy, while
being tethered to the membrane itself
by the hydrophobic residues of the
transmembrane region (Figure 1B).
In this conformation, the authors
supposed that DesK autokinase
activity would be low. A drop in
temperature, conversely, would
increase lipid ordering, resulting in
a thicker plasma membrane. In this
scenario, the authors predicted that
these hydrophilic residues would
become forcibly buried into the
hydrophobic lipid bilayer, resulting
in a conformational change that
would activate the autokinase activity
of DesK. To test this, the authors
lengthened the transmembrane region
of the thermo-sensor so that the ‘buoy’
was farther away from the surface of
the membrane and would not be pulled
into the bilayer when the membrane
